arrow
A

Antonella Castagna

IRCCS San Raffaele Scientific Institute
H指数:61
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry

病毒学结局、耐药谱和病毒进化:基于lenacapavir的治疗方案在治疗经验丰富的患者中的表现——PRESTIGIO登记研究数据

2026-10-280
OAAI
Empirical Therapy in High-Risk Hematological Patients with Carbapenem-Resistant Enterobacterales Colonization: Real-World Treatment Decisions and Antimicrobial Stewardship Implications

在高风险血液病患者中,对碳青霉烯耐药肠杆菌科细菌定植的的经验性治疗:真实世界治疗决策和抗菌药物合理使用的影响

2026-10-080
OA
Stability of the HIV cascade of care throughout the COVID-19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)

欧洲COVID-19大流行期间HIV治疗护理连续性稳定性:跨国EuroSIDA队列研究(2016–2022)的结果

2026-09-300
OAAI
First virological control after >30 years of antiretroviral therapy in extensively drug-resistant HIV: potential role of lenacapavir plus ibalizumab

广泛耐药HIV患者在>30年抗逆转录病毒治疗后的首次病毒学控制:lenacapavir联合ibalizumab的潜在作用

2026-09-110
PRE
Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND

整合酶抑制剂为基础的抗逆转录病毒疗法的心血管疾病风险:一项在RESPOND中的因果推断分析

2026-08-060
OAAI
Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry

在PRESTIGIO登记研究中,重度治疗经验的HIV感染者血浆中枢神经系统生物标志物

AIDS
IF3.1
2026-07-010
PRE
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era

现代抗逆转录病毒治疗时代下,HIV感染者中持续低水平病毒血症人群转换治疗方案的有效性

2026-04-290
PRE
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial
2025-11-260
PRE
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study

HIV感染者与非感染者肝细胞癌诊断后的5年生存率比较:一项多中心研究

2025-11-181
OAAI
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: preliminary observations from the PRESTIGIO Registry

抗A簇抗体和抗p24抗体在多重耐药HIV感染者中的初步观察:PRESTIGIO登记研究的初步结果

2025-11-030
PRE
Clinical characteristics, management, and outcome of vertebral osteomyelitis with known versus unknown aetiology: a single-centre retrospective study between 2017-2023

椎骨骨髓炎的临床特征、治疗管理及预后:已知与未知病因的单中心回顾性研究(2017-2023)

2025-11-030
PRE
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus dolutegravir as a two-drug regimen in adults naive to antiretroviral therapy (DYNAMIC): 24-week results from a randomised phase 2b study

HIV-1成熟抑制剂GSK3640254联合多替拉韦作为双药方案在抗逆转录病毒治疗初治成人中的疗效与安全性(DYNAMIC):一项随机Ⅱb期研究的24周结果

2025-10-170
OAAI
Use of Preventive Measures for Cardiovascular Disease in People With HIV

艾滋病感染者中预防心血管疾病的措施应用

2025-10-010
OAAI